Description

Mounjaro 2.5 mg KwikPen (Tirzepatide Injection)

Product Overview

Mounjaro 2.5 mg contains tirzepatide, a prescription medicine that acts on GIP and GLP-1 receptors. It is used in adults with type 2 diabetes to improve blood glucose control alongside a healthy diet and regular physical activity.

Key Features

• Brand Name: Mounjaro
• Active Ingredient: Tirzepatide
• Strength: 2.5 mg
• Dosage Form: Subcutaneous injection
• Product Type: Prescription medicine
• Initial Dose: Generally 2.5 mg once weekly, as prescribed by a healthcare professional.

Benefits

• Helps improve blood sugar control in adults with type 2 diabetes.
• Works through GIP and GLP-1 receptors.
• May help reduce appetite and body weight.
• Supports diabetes management when combined with diet and physical activity.

Administration

Mounjaro is administered under the skin as directed by the prescribing healthcare professional. Follow the product-specific instructions for use. Do not change the dose or frequency without medical advice.

Storage Instructions

• Store unopened pens in a refrigerator at 2°C–8°C.
• Do not freeze.
• Protect the medicine from excessive heat and light.
• Follow the manufacturer’s instructions for in-use storage and the permitted period outside refrigeration.

Important Safety Information

Mounjaro is a prescription medicine and should be used only under medical supervision. Common side effects may include nausea, vomiting, diarrhoea, constipation and reduced appetite. It may not be suitable for everyone.

Consult your doctor before use, particularly if you have a history of pancreatitis, severe gastrointestinal problems, or are taking other medicines that lower blood glucose.

Prescription Required: Use only as prescribed by a registered medical practitioner.

Disclaimer: Product information is provided for educational purposes. Always refer to the approved package insert and prescription for complete instructions.